Oppenheimer Comments on Compugen Ltd.'s FY2026 Earnings (NASDAQ:CGEN)

Compugen Ltd. (NASDAQ:CGEN – Get Rating) – Equities research analysts at Oppenheimer issued their FY2026 earnings per share estimates for Compugen in a report released on Friday, February 25th. Oppenheimer analyst M. Breidenbach expects that the biotechnology company will post earnings of ($0.65) per share for the year. Oppenheimer has a “Outperform” rating and a […]

Related Keywords

Israel ,Simchon Faigler ,Eli Mintz ,Goldman Sachs Group Inc ,Compugen Ltd ,Stifel Financial Corp ,Zacks Investment Research ,Compugen ,Nasdaq ,Eagle Rock Investment Company ,Antonetti Capital Management ,Walleye Trading ,Get Rating ,Investment Research ,Rock Investment Company ,Sachs Group ,Capital Management ,Amir Natan ,Nasdaq Cgen ,Ocgen ,Medical ,Earnings Estimates ,Oppenheimer Holdings Inc ,